Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.30
+0.15 (0.93%)
Jul 31, 2026, 4:08 PM HKT
Qyuns Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Qyuns Therapeutics stock have an average target of $33.00, which predicts a 102.45% increase from the current stock price of 16.3.
Price Target: $33.00 (+102.45%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 9, 2026.
Analyst Ratings
The average analyst rating for Qyuns Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Jan '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 1 |
| Buy | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Huachuang Securities No rating | Huachuang Securities | Buy Maintains $37.35 | Buy | Maintains | $37.35 | +129.14% | Apr 9, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $33.00 | Buy | Maintains | $33.00 | +102.45% | Apr 4, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $30.15 | Buy | Maintains | $30.15 | +84.97% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
535.00M
from 806.96M
Decreased by -33.70%
Revenue Next Year
512.00M
from 535.00M
Decreased by -4.30%
EPS This Year
1.00
from 1.84
Decreased by -45.54%
EPS Next Year
0.63
from 1.00
Decreased by -37.52%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.